Original Article(s)

Squamous cell carcinoma of the anus: morphological evaluation and ancillary techniques

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 30 September 2026
45
Views
20
Downloads

Authors

Background: the present study deals with anal carcinoma, focusing on morphological evaluation, histopathological characteristics, and immunophenotypic profile, as well as the incidence, risk factors, and molecular profile of this pathology, underlining the importance of a correct differential diagnosis.

Materials and Methods: this study was conducted in the laboratory of Anatomic Pathology at the Santa Rita Clinic, Monza Policlinic Group, located in Vercelli. We collected samples of 13 anal biopsies with a diagnosis of squamous cell carcinoma of the anus, referred from April 2022 to February 2025. A retrospective analysis was performed on paraffin-embedded Hematoxylin and Eosin (H&E) and immunohistochemical samples.

The study contributed to expanding the case history present in the literature and allowed for a review of the differential diagnostic criteria in light of the immunophenotypic expression of neoplastic subtypes.

The morphological analysis was performed by microscopic observation of the hematoxylin and eosin-stained specimen slide, while immunophenotypic analysis was performed by immunohistochemical staining of the specimen with specific antibodies (anti-pan keratin, anti-keratin, anti-CK8/18, anti-CK7, anti-p16INK4a, anti-p40, GATA3, anti-chromogranin A, anti-synaptophysin) and subsequent microscopic examination. Morphological analysis allowed for the identification of histotypes, while immunohistochemical analysis allowed for a differential diagnosis with other anal canal tumors.

Results: from the analysis of the case history, it was seen, in agreement with other previous studies, that this pathology is rare, as it is found in 3% of biopsies of the anal region, that it has a higher incidence in females, and, in the majority of cases, the neoplasm is related to Human Papillomavirus (HPV) infection.

Conclusions: anal squamous cell carcinoma is a rare but increasing neoplasm, with variable histological characteristics that can lead to misdiagnosis. Therefore, a correct differential diagnosis through analysis of morphology and immunophenotypic expression is essential. HPV infection is a significant risk factor, and vaccination in at-risk populations could reduce its incidence.

Downloads

Download data is not yet available.

Citations

1.Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Fourth edition. International Agency for Research on Cancer; Lyon, France; 2010.
3.World Health Organization (WHO). Global Cancer Observatory. Available from: https://gco.iarc.fr/en
4.Associazione Italiana di Oncologia Medica (AIOM). Linee guida AIOM: neoplasie del retto e dell’ano. 2024. Available from: https://www.aiom.it
5.Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
6.Meyer J, Kachnic L. Epidemiology and pathogenesis of anal cancer. Springer Nature; Berlin, Germany; 2019.
7.Vonsky M, Shabaeva M, Runov A, et al. Carcinogenesis associated with human papillomavirus infection. Mechanisms and potential for immunotherapy. Biochemistry (Mosc) 2019;84:782-99.
8.Clifford GM, Georges D, Shiels MS, et al. A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer 2021;148:38-47.
9.Rao S, Guren MG, Khan K, et al. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2021;32:1087-100.
10.Gondal TA, Chaudhary N, Bajwa H, et al. Anal cancer: the past, present and future. Curr Oncol 2023;30:3232-50.
11.Valvo F, Ciurlia E, Avuzzi B, et al. Cancer of the anal region. Crit Rev Oncol Hematol 2019; 135:115-27.
12.Perry WB, Connaughton JC. Abdominoperineal resection: how is it done and what are the results? Clin Colon Rectal Surg 2007;20:213-20.
13.Boman BM, Moertel CG, O’Connell MJ, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984;54:114-25.
14.Schraut WH, Wang CH, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983;51:1291-6.
15.Mignozzi S, Santucci C, Malvezzi M, et al. Global trends in anal cancer incidence and mortality. Eur J Cancer Prev 2024;33:77-86.
16.Fenger C, Frisch M, Jass JJ, et al. Anal cancer subtype reproducibility study. Virchows Arch 2000;436:229-33.
17.Patel KS, Alhatem A, Gadde U, et al. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma. Cancer Epidemiol 2020;67:101723.
18.Welten VM, Fields AC, Malizia RA, et al. The association between sex and survival for anal squamous cell carcinoma. J Surg Res 2021;268:474-84.
19.Daling JR, Weiss NS, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med N 1987;317:973-7.
20.Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med 2020;17:864-78.
21.Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997;50:625-34.
22.Machalek DA, Grulich AE, Hillman RJ, et al. The study of the prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health 2013;13:946.
23.Palefsky JM, Lee JY, Jay N, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med 2022;386:2273-82.
24.Hoff PM, Coudry R, Moniz CM. Pathology of anal cancer. Surg Oncol Clin N Am 2017;26:57-71.
Carlotta Garanzini, Department of Science and Technological Innovation, University of Eastern Piedmont UPO “Amedeo Avogadro”, Alessandria

Laureata in Biologia Biomedico Biomolecolare presso l'Università del Piemonte Orientale

Stefania Erra, Anatomic Pathology Laboratory, Santa Rita Clinic, Policlinic of Monza Group, Vercelli

Medico Anatomo Patologo presso la clinica S. Rita

Elia Ranzato, Department of Science and Technological Innovation, University of Eastern Piedmont UPO “Amedeo Avogadro”, Alessandria
Professore associato di Biologia Cellulare e ricercatore all'Università del Piemonte Orientale (UPO)
 
 

How to Cite



Squamous cell carcinoma of the anus: morphological evaluation and ancillary techniques. (2026). Working Paper of Public Health, 14(1). https://doi.org/10.4081/wpph.2026.10594